H-magnetic resonance spectroscopy-determined cerebral lactate and poor neurological outcomes in children with central nervous system disease

Annals of Neurology

Volumn 41, Issue 4, 1997, Pages 470-481

  Ashwal, Stephen ^a   Holshouser, Barbara A ^a   Tomasi, Lawrence G ^a   Shu, Stanford ^a   Perkin, Ronald M ^a   Nystrom, Gerald A ^a   Hinshaw Jr , David B ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATINE; LACTIC ACID; N ACETYLASPARTIC ACID; LACTIC ACID DERIVATIVE;

ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISABLED PERSON; FEMALE; GRAY MATTER; HEART ARREST; HUMAN; HYPERGLYCEMIA; INFANT; INJURY SCALE; MALE; MORTALITY; NEWBORN; PERSISTENT VEGETATIVE STATE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TREATMENT OUTCOME; WHITE MATTER; BRAIN CORTEX; BRAIN DISEASE; BRAIN INJURY; CHILD; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OUTCOME ASSESSMENT; SENSITIVITY AND SPECIFICITY;

BRAIN DISEASES; BRAIN INJURIES; CEREBRAL CORTEX; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFANT, NEWBORN; LACTATES; MAGNETIC RESONANCE SPECTROSCOPY; OUTCOME ASSESSMENT (HEALTH CARE); SENSITIVITY AND SPECIFICITY;

EID: 0030612038     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410410410     Document Type: Article

References (55)

1. Ross BD, Kreis R, Ernst T. Clinical tools for the 90s: magnetic resonance spectroscopy and metabolite imaging. Eur J Radiol 1992;14:128-140
2. Gadian DG, Williams SR, Bates TE, Kauppinen RA. NMR spectroscopy: current status and future possibilities. Acta Neu- rochir Suppl (Wein) 1993;57:l-8
3. Prichard JW. Magnetic resonance spectroscopy of cerebral me- tabolism in vivo. In: Asbury AK, McKhann GM, McDonald WI, eds. Diseases of the nervous system clinical neurobiology, vol 2. New York: WB Saunders, 1993:1589-1605
4. Auld KL, Ashwal S, Holshouser BA, et al. Proton magnetic resonance spectroscopy in children with acute central nervous system injury. Pediatr Neurol 1995;12:323-334
5. Wang Z, Zimmerman RA, Sauter R. Proton MR spectroscopy of the brain: clinically useful information obtained in assessing CNS diseases in children. AJR 1996;167:191-199
6. Kreis R, Arcinue E, Ernst T, et al. Hypoxie encephalopathy after near-drowning studied by quantitative 'H-magnetic resonance spectroscopy. J Clin Invest 1996;97:1142-1154
7. Lanfermann H, Kugel H, Heindel W, et al. Metabolie changes in acute and subacute cerebral infarctions: findings at proton MR spectroscopic imaging. Radiology 1995;196:203-210
8. Mathews VP, Barker PB, Blackband SJ, et al. Cerebral metab- olites in patients with acute and subacute strokes: concentra- tions determined by quantitative proton MR spectroscopy. AJR 1995;165:633-638
9. Berek K, Lechlcitncr P, Luef G, et al. Early determination of neurological outcome after prehospital cardiopulmonary resus- citation. Stroke 1995;26:543-549
10. Graham GD, Blamire AM, Rothman DL, et al. Early temporal variation of cerebral metabolites after human stroke. A proton magnetic resonance spectroscopy study. Stroke 1993;24:1891- 1896
11. Holshouser BA, Ashwal S, Luh GY, et al. 1H-MR spectroscopy after acute CNS injury: outcome prediction in neonates, infants and children. Radiology 1997 (in press)
12. Fiser DH. Assessing the outcome of pediatrie intensive care. J Pediatr 1992;121:68-74
13. van der Knapp MS, van der Grond J, van Rijen PC, et al. Age dependent changes in localized proton and phosphorus MR spectroscopy of the brain. Radiology 1990;176:509-515
14. Kreis R, Ernst T, Ross BD. Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med 1993;30:424-437
15. Kimura H, Fujii Y, Itoh S, et al. Metabolic alterations in the neonate and infant brain during development: evaluation with proton MR spectroscopy. Radiology 1995;194:483-489
16. Cady EB, Lorek A, Penrice J, et al. Detection of propane-1,2- diol in neonatal brain by in vivo proton magnetic resonance spectroscopy. Magn Reson Med 1994;32:764-767
17. Azzopardi D, Edwards D. Magnetic resonance spectroscopy in neonates. Curr Opin Neurol 1995;8:145-149
18. Confort-Gouny S, Vion-Dury J, Nicoli F, et al. A multipara- metric data analysis showing the potential of localized proton MR spectroscopy of the brain in the metabolic characterization of neurological diseases. J Neurol Sci 1993;118:123-133
19. Tien RD, Lai PH, Smith JS, Lazeyras F. Single-voxel proton brain spectroscopy (PROBE/SV) in patients with primary brain tumors. AJR 1996;167:201-209
20. Yamagata NT, Miller BL, McBride D, et al. In vivo proton spectroscopy of intracranial infections and neoplasms. J Neuro- imaging 1994;4:23-28
21. Barker PB, Lee RR, McArthur JC. AIDS dementia complex: evaluation with proton MR spectroscopic imaging. Radiology 1995;195:58-64
22. Barker PB, Bryan RN, Kumar AJ, Naidu S. Proton NMR spec- troscopy of Canavan's disease. Neuropediatrics 1992;23:263- 267
23. Cross JH, Gadian DG, Connelly A, Leonard JV. Proton mag- netic resonance spectroscopy studies in lactic acidosis and mi- tochondrial disorders. J Inherit Metab Dis 1993;16:800-811
24. Barkovich AJ, Good WV, Koch TK, Berg BO. Mitochondrial disorders: analysis of their clinical and imaging characteristics. Am J Neuroradiol 1993;14:1119-1137
25. Krageloh-Mann I, Grodd W, Schoning M, et al. Proton spec- troscopy in five patients with Leigh's disease and mitochondrial enzyme deficiency. Dev Med Child Neurol 1993;35:769- 776
26. Felber SR, Sperl W, Chemelli A, et al. Maple syrup urine disease: metabolic decompensation monitored by proton mag- netic resonance imaging and spectroscopy. Ann Neurol 1993;33:396-401
27. Shevell MI, Matthews PM, Scriver CR, et al. Cerebral dysgen- esis and lactic acidemia: an MRI/MRS phenorype associated with pyruvate dehydrogenase deficiency. Pediatr Neurol 1994;11:224-229
28. Cross JH, Connelly A, Gadian DG, et al. Clinical diversity of pyruvate dehydrogenase deficiency. Pediatr Neurol 1994;10:276-283
29. Castillo M, Kwock L, Green C. MELAS syndrome: imaging and proton MR spectroscopic findings. Am J Neuroradiol 1995;16:233-239
30. Duncan DB, Herholz K, Kugel H, et al. Positron emission to- mography and magnetic resonance spectroscopy of cerebral gly- colysis in children with congenital lactic acidosis. Ann Neurol 1995:37:351-358
31. Kreis R, Pfenninger J, Herschkowitz N, Boesch C. In vivo pro- ton magnetic resonance spectroscopy in a case of Reyc's syn- drome. Intensive Care Med 1995;21:266-269
32. Sutton LN, Wang Z, Gusnard D, et al. Proton magnetic reso- nance spectroscopy of pediatrie brain tumors. Neurosurgery 1992;31:195-202
33. Sutton LN, Wehrli SL, Gennarelli L, et al. High-resolution IH-magnetic resonance spectroscopy of pediatrie posterior fossa tumors in vitro. J Neurosurg 1994;81:443-448
34. Kruse B, Hanefeid F, Christen HJ, et al. Alterations of brain metabolites in metachromatic leukodystrophy as detected by lo- calized proton magnetic resonance spectroscopy in vivo. J Neu- rol 1993;241:68-74
35. Hanefeid F, Holzbach U, Kruse B, et al. Diffuse white matter disease in three children; an encephalopathy with unique fea- tures on magnetic resonance imaging and proton magnetic res- onance spectroscopy. Neuropediatrics 1993;24:244-248
36. Kruse B, Barker PB, van Zijl PC, et al. Multislice proton mag- netic resonance spectroscopic imaging in X-linked adrenoleu- kodystrophy. Ann Neurol 1994;36:595-608
37. Tedeschi G, Schiffmann R, Barton NW, et al. Proton magnetic resonance spectroscopic imaging in childhood ataxia with dif- fuse central nervous system hypomyelination. Neurology 1995;45:1526-1532
38. Wang Z, Bogdan AR, Zimmerman RA, et al. Investigation of stroke in sickle cell disease by 1H nuclear magnetic resonance spectroscopy. Neuroradiology 1992;35:57-65
39. Felber SR, Ettl AR, Birbamer GG, et al. MR imaging and pro- ton spectroscopy of the brain in posttraumatic cortical blind- ness. J Magn Reson Imaging 1993;3:921-924
40. Sutton LN, Wang Z, Duhaime AC, et al. Tissue lactate in pe- diatrie head trauma: a clinical study using 1H NMR spectros- copy. Pediatr Neurosurg 1995;22:81-87
41. Kugel H, Roth B, Heindel W, Lackner K. Proton MR spec- troscopy in infants with hypoxic ischemic encephalopathy and energy deficiency syndromes. SMRM 1993;WIP: p 320. Abstract presented at the 12th Annual Meeting, August 14-20, New York.
42. Groenendaal F, Veenhoven RH, van der Grond J, et al. Cere- bral lactate and N-acetyl-aspartate/choline ratios in asphyxiated full-term neonates demonstrated in vivo using proton magnetic resonance spectroscopy. Pediatr Res 1994;35:148-151
43. Azzopardi D, Edwards D. Magnetic resonance spectroscopy in neonates. Curr Opin Neurol 1995;8:145-149
44. Ma S, Shieh LI, Huang CC. High-resolution proton nuclear magnetic resonance studies of urine from asphyxiated newborn infants. Appl Biochem Biotechnol 1995;53:37-51
45. Peden CJ, Cowan FM, Bryant DJ, et al. Proton MR spectros- copy of the brain in infants. J Comput Assist Tomogr 1990;14:886-894
46. 1H-MRS in the evaluation of children with congenital heart disease and acute CNS injury. J Thorac Cardiothorac Surg 1996;112:1-12
47. Siesjo BK. Acidosis and ischemic brain damage. Neurochem Pathol 1988;9:31-88
48. Petroff OA, Graham GD, Blamire AM, et al. Spectroscopic im- aging of stroke in humans: histopathology correlates of spectral changes. Neurology 1992;42:1349-1355
49. Longstreth WT, Inui TS. High blood glucose level on hospital admission and poor neurological recovery after cardiac arrest. Ann Neurol 1984;15:59-63
50. Ashwal S, Schneider S, Tomasi L, Thompson J. Prognostic im- plications of hyperglycemia and reduced cerebral blood flow in childhood near drowning. Neurology 1990;40:820-823
51. Vannucci RC, Yager JY. Glucose, lactic acid, and perinatal hypoxic-ischemic brain damage. Pediatr Neurol 1992;8:3-12
52. Welch KMA, Levine SR, Martin G, et al. Magnetic resonance spectroscopy in cerebral ischemia. Neurol Clin 1992;10:1-29
53. Young RSK, Petroff OAC, Aquila WJ, et al. Hyperglycemia and the rate of lactic acid accumulation during cerebral isch- emia in developing animals: in vivo proton MRS study. Biol Neonate 1992;61:235-242
54. 1H-MRS obtained 3 to 5 days after acute CNS injury predicts outcome in children 18 months or older. Ann Neurol 1995;38:552 (Abstract)
55. de Graaf RA, Luc Y, Terpstra M, Garwood M. Spectral editing with adiabatic pulses. J Magn Reson B 1995;109:184-193